The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer.
The hepatitis B virus (HBV) genome contains a specific DNA binding site for the glucocorticoid receptor. Using DNase I footprinting, this binding site was localized at HBV map positions 341-370 clockwise from the EcoRI site. The DNA sequence protected in the footprint contains two tandem copies of the GRE core hexanucleotide 5'-TGTTCCT-3'. Deletion analysis and reconstruction experiments in plasmid expression vectors demonstrated that this glucocorticoid receptor binding sequence serves as a signal for augmenting glucocorticoid-dependent activity of the HBV enhancer, which is located approximately 730 nucleotides downstream in the HBV genome. Even though it does not serve as an independent enhancer element, the HBV glucocorticoid receptor domain can therefore be categorized as a functional GRE.
Tur-Kaspa
R
R
Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461.
Shaul
Y
Y
Moore
D D
DD
Burk
R D
RD
Okret
S
S
Poellinger
L
L
Shafritz
D A
DA
D001483:Base Sequence; D004274:DNA, Recombinant; D004279:DNA, Viral / Q000235:genetics*; D003907:Dexamethasone / Q000494:pharmacology; D004742:Enhancer Elements, Genetic; D005786:Gene Expression Regulation; D006515:Hepatitis B virus / Q000235:genetics*; D011965:Receptors, Glucocorticoid / Q000235:genetics*; D012045:Regulatory Sequences, Nucleic Acid
D004274:DNA, Recombinant; D004279:DNA, Viral; D011965:Receptors, Glucocorticoid; D003907:Dexamethasone